How do agonistic IR antibodies achieve selective immune suppression without compromising protective immunity?

OPEN

The abstract describes IR agonists suppressing pathological T cell functions while promoting tolerance, but the mechanisms ensuring selectivity are unexplained. This mechanistic gap is crucial for avoiding immunocompromise in treated patients. Gap type: unexplained_observation Source paper: Inhibitory receptor agonists: Emerging strategies in immune modulation. (2026, J Exp Med, PMID:41915422)

Priority: 0.57 Domain: immunotherapy Hypotheses: 0

📊 Landscape Analysis

Landscape Summary: How do agonistic IR antibodies achieve selective immune suppression without compromising protective immunity? is a 0.57 priority gap in immunotherapy. It has 0 linked hypotheses with average composite score 0.000. Status: open.

Key Unanswered Questions

What is the optimal TREM2 modulation strategy across disease stages?
How does DAM activation state affect therapeutic outcomes?
What biomarkers predict response to TREM2-targeted interventions?

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

How do agonistic IR antibodies achieve selective immune suppression without compromising protective immunity? — INVOKE-2 (completed)

📈 Living Dashboards

0

Hypotheses

0.000

Top Score

0.000

Avg Score

0

Debates

0.00

Avg Quality

0%

Resolution

0

Mechanistic Families

Gap Resolution Progress0%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

No hypotheses linked to this gap yet.

🌊 Knowledge Graph Connections

activates (15)

IR→neuroinflammationIR→NLRP3IR→TNFIR→strokeBACE1→IR

▸ Show 10 more

IR→METCERS2→IRANGPT1→IRHDAC3→IRIR→JNKH2AX→IRAMPK→IRIR→diabetesHIF→IRIR→PINK

associated with (9)

CLCN1→IRCP→IRALOX12→IRIR→neuroinflammationHDAC3→IR

▸ Show 4 more

H2AX→IRIR→Alzheimer's diseaseIR→diabetesIR→LDL

biomarker for (1)

data in (2)

benchmark_ot_ad_answer_key:IR→IRIR→benchmark_ot_ad_answer_key:IR

expressed in (2)

IR→macrophagesIR→TH

inhibits (8)

DNA→IRIR→TGM2HDAC3→IRIR→neurodegenerationATM→IR

▸ Show 3 more

IR→NBS1IR→PARP1IR→RAD51

interacts with (3)

IR→MAP2IR→neurodegenerationIR→neuroinflammation

participates in (4)

IR→ferroptosisIR→oxidative stress responseIR→PI3K-AKT-mTOR signalingIR→synaptic plasticity

protects against (2)

HDAC3→IRIR→diabetes

regulates (2)

IR→PSEN1IR→LRP2

targets (2)

IR→LRP2metformin→IR

🕑 Activity Feed

No activity recorded yet.

💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

Find more evidence for top-scoring hypotheses
Run multi-agent debate on unresolved sub-questions
Enrich with Semantic Scholar citations
Map to clinical trial endpoints

← Back to All Gaps